z-logo
open-access-imgOpen Access
Novel HNF1A gene mutation in maturity-onset diabetes of the young: A case report
Author(s) -
Qian Xu,
Chengxia Kan,
Ningning Hou,
Xiaodong Sun
Publication year - 2022
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v10.i6.1909
Subject(s) - medicine , hnf1a , sulfonylurea , maturity onset diabetes of the young , gliclazide , glucokinase , diabetes mellitus , glycemic , galactosemia , sanger sequencing , nonsense mutation , mutation , insulin , gene mutation , gene , endocrinology , type 2 diabetes , genetics , biology , missense mutation , galactose , biochemistry
Maturity-onset diabetes of the young 3 (MODY3), caused by mutations in the HNF1A gene, is the most common subtype of MODY. The diagnosis of MODY3 is critical because a low dose of sulfonylurea agents can achieve glucose control.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here